SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-08-014404
Filing Date
2008-06-05
Accepted
2008-06-05 06:05:27
Documents
25
Period of Report
2008-06-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 SCOLR PHARMA, INC 8K 6-4-2008 form8k.htm 8-K 20614
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 115121
3 ex99_11.jpg GRAPHIC 74772
4 ex99_12.jpg GRAPHIC 15372
5 ex99_13.jpg GRAPHIC 15372
6 ex99_14.jpg GRAPHIC 15372
7 ex99_15.jpg GRAPHIC 15372
8 ex99_16.jpg GRAPHIC 15372
9 ex99_17.jpg GRAPHIC 15372
10 ex99_18.jpg GRAPHIC 91710
11 ex99_19.jpg GRAPHIC 217544
12 ex99_110.jpg GRAPHIC 158706
13 ex99_111.jpg GRAPHIC 53191
14 ex99_112.jpg GRAPHIC 60868
15 ex99_113.jpg GRAPHIC 180729
16 ex99_114.jpg GRAPHIC 146042
17 ex99_115.jpg GRAPHIC 232698
18 ex99_116.jpg GRAPHIC 133976
19 ex99_117.jpg GRAPHIC 15372
20 ex99_118.jpg GRAPHIC 15372
21 ex99_119.jpg GRAPHIC 20597
22 ex99_120.jpg GRAPHIC 21037
23 ex99_121.jpg GRAPHIC 89399
24 ex99_122.jpg GRAPHIC 81439
25 ex99_123.jpg GRAPHIC 74551
  Complete submission text file 0001140361-08-014404.txt   2565469
Mailing Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006
Business Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006 4253730171
SCOLR Pharma, Inc. (Filer) CIK: 0000934936 (see all company filings)

IRS No.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31982 | Film No.: 08881894
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1